Home » Medical Devices » Calprotectin Testing Market

Calprotectin Testing Market By Test Kits (Calprotectin ELISA Test Kits, Calprotectin Rapid Testing Kits) By Indication (Stool, Blood Serum/Plasma, Other Biological Indications) By Indication (Irritable Bowel Syndrome, Ulcerative Colitis, Crohn’s Disease, Colorectal Cancer) By End User (Hospitals, Diagnostic Laboratories, Specialty Clinics)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the Report

The global Calprotectin testing market is divided into the following segments: test kits, sample, indication, end-user, and region. The main segment is stools, while the two primary test kit portions are ELISA and calprotectin rapid testing kits. The irritable bowel syndrome category accounted for the majority of the global market. The diagnostic laboratories category is expected to be the second-largest market for Calprotectin testing after hospitals, with North America dominating the market expansion.

The global Calprotectin testing market is being driven by various factors, including the fact that Inflammatory Bowel Disease (IBD) is becoming more prevalent, and the need of early detection and treatment is becoming more generally acknowledged. Furthermore, Calprotectin testing is still standardized, and reimbursement standards are in place. The market, however, faces substantial hurdles, such as patients’ and healthcare professionals’ lack of awareness of calprotectin testing, as well as the high cost of calprotectin testing, which may limit penetration, particularly in developing countries.

Nonetheless, the global Calprotectin testing market provides considerable potential opportunities, with Non-Invasive Diagnostic Tools in high demand and an increased emphasis on non-invasive testing. Furthermore, increased awareness of the benefits of calprotectin testing is expected to boost demand for these tests.

What Are the Primary Forces Driving the Global Calprotectin Testing Market?

Several factors are driving the global Calprotectin testing market, including the fact that Inflammatory Bowel Disease (IBD) is becoming more common, and the need of early detection and treatment is becoming more generally acknowledged.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

What Are the Global Calprotectin Testing Market’s Major Challenges?

Patients’ and healthcare professionals’ lack of awareness of calprotectin testing, as well as the high cost of calprotectin testing, may hinder uptake, particularly in developing countries.

What Are the Opportunities for Growth in the Global Calprotectin Testing Market?

The global Calprotectin testing market provides considerable potential opportunities, with Non-Invasive Diagnostic Tools in high demand and an increased emphasis on non-invasive testing.

Executive Summary

Overview of the Global Calprotectin testing market

The Calprotectin Testing Market is the market for medical tests that assess calprotectin levels in a patient’s stool or blood. Calprotectin is a protein produced by white blood cells in reaction to inflammation in the body, and elevated levels of calprotectin can suggest the existence of IBD or other gastrointestinal illnesses. Calprotectin Testing Market comprises a variety of diagnostic tests and devices used to assess calprotectin levels, such as ELISA testing, lateral flow assays, and point-of-care tests. The growing prevalence of IBD and other gastrointestinal disorders, as well as the growing demand for non-invasive diagnostic tests that can deliver accurate and consistent results, are driving the market.

Market Definition

The Calprotectin Testing Market is expanding as the prevalence of inflammatory bowel disease (IBD) and other gastrointestinal illnesses rises. ELISA tests, lateral flow assays, and point-of-care tests are among the diagnostic tests and equipment available to evaluate calprotectin levels in a patient’s feces or blood. Due to factors including growing demand for non-invasive diagnostic tests, the creation of new and more precise testing techniques, and raised awareness of the significance of early identification and treatment of gastrointestinal problems, the market is anticipated to grow even more in the next years.

Market Insights

The global demand for Calprotectin testings was valued at USD 195.8 Billion in 2022 and is expected to reach USD 290.5 Billion in 2030, growing at a CAGR of 5.80% between 2023 and 2030.
In 2022, the enzyme linked immunosorbent assay (ELISA) segment was expected to dominate the global fecal calprotectin test market, Calprotectin Rapid Testing Kits segment contributes rest of the demand in the market.
The Stool segment is the main segment due of its excellent accuracy and non-invasive character, Blood Serum/Plasma is another segment but contributes very little to the global Calprotectin testing market
In 2022, the irritable bowel syndrome segment held the largest proportion of the global market, the Ulcerative Colitis category is predicted to develop at the fastest CAGR (Compound Annual Growth Rate).
The hospitals segment dominated the global fecal calprotectin test market in 2022, the Diagnostic Laboratories category is predicted to be the second-largest market for Calprotectin testing
North America is projected to lead the Calprotectin testing market; the Asia Pacific area is predicted to be the fastest-growing market.
The key drivers of the market are the increasing prevalence of Inflammatory Bowel Disease (IBD) and the growing recognition of the need of early detection and treatment.
The primary constraints are that calprotectin testing is still standardized and that policies of limited reimbursement are in place.
Non-Invasive Diagnostic Tools are in high demand, and the emphasis on non-invasive testing is growing. These are the primary market potential.

Market Overview

The global Calprotectin testing market has witnessed steady growth in recent years and is expected to continue growing at a CAGR of 5.80% between 2023 and 2030. The market was valued at USD 195.8 Billion in 2022 and is expected to reach USD 290.5 Billion in 2030.

Segmentation by Test Kits

In 2022, the enzyme linked immunosorbent assay (ELISA) segment was expected to dominate the global fecal calprotectin test market.
Calprotectin Rapid Testing Kits segment contributes rest of the demand in the market.

Segmentation by Sample

The Stool segment is the main segment due of its excellent accuracy and non-invasive character.
Blood Serum/Plasma is another segment but contributes very little to the global Calprotectin testing market

Segmentation by Indication

In 2022, the irritable bowel syndrome segment held the largest proportion of the global market.
In the Calprotectin testing market, the Ulcerative Colitis category is predicted to develop at the fastest CAGR (Compound Annual Growth Rate).

Segmentation by End-User

The hospitals segment dominated the global fecal calprotectin test market in 2022.
After hospitals, the Diagnostic Laboratories category is predicted to be the second-largest market for Calprotectin testing.

Segmentation by Region

North America is projected to lead the Calprotectin testing market.
The Asia Pacific area is predicted to be the fastest-growing market for Calprotectin testing.
The rest of the World, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for Calprotectin testings.

The rising demand for Calprotectin tests can be due to the fact that Inflammatory Bowel Disease (IBD) is becoming more common, and the need of early detection and treatment is becoming more generally acknowledged. However, the market is constrained since Calprotectin testing is still standardized, and reimbursement regulations are in place.

North America is likely to dominate the Calprotectin testing market due to the region’s high prevalence of inflammatory bowel disease and other gastrointestinal illnesses. The market is being pushed by factors such as increased awareness and adoption of Calprotectin testing, the availability of modern healthcare infrastructure, and the presence of prominent players in the region. Due to the rising prevalence of chronic illnesses across the continent, Europe is anticipated to be the second-largest market.

The Asia Pacific region is predicted to be the fastest-growing market, owing to increased awareness and use of Calprotectin testing in countries such as China and India. The market is also predicted to grow in Latin America, the Middle East, and Africa, albeit at a slower rate because to a lack of knowledge and infrastructure in these regions.

Market Drivers

The global Calprotectin testing market is driven by several factors. The following are the key drivers of the global Calprotectin testing market:

Inflammatory Bowel Disease (IBD) is becoming more common.

Inflammatory bowel disease (IBD) is a chronic inflammatory illness of the digestive tract that encompasses Crohn’s disease and ulcerative colitis. IBD affects millions of individuals globally, and its incidence is rising, particularly in wealthy countries. According to the Crohn’s and Colitis Foundation, over 3 million adults in the United States have IBD, with that figure anticipated to rise to over 3.5 million by 2025.

Calprotectin is a protein produced by white blood cells in reaction to inflammation in the body, and high calprotectin levels can suggest the existence of IBD or other gastrointestinal illnesses. Calprotectin testing is a non-invasive, low-cost method of diagnosing IBD that is increasingly being utilized as a first-line diagnostic tool for these illnesses.

The demand for calprotectin testing is predicted to increase as the prevalence of IBD rises. Furthermore, as these tests become more generally available and inexpensive, the development of new and more accurate testing methods is likely to drive future expansion in the Calprotectin Testing Market.

Increasing Recognition of the Importance of Early Detection and Treatment

Early detection and treatment of gastrointestinal diseases including inflammatory bowel disease (IBD) are crucial for improving patient outcomes and lowering healthcare costs. Calprotectin testing is a non-invasive, low-cost method of diagnosing these disorders, and it is increasingly being employed as a first-line diagnostic tool.

One of the primary drivers of the Calprotectin Testing Market is the growing awareness of the necessity of early identification and treatment. Patients and healthcare providers are increasingly understanding the benefits of early detection and treatment and are looking for diagnostic tools that can aid in the early detection of these disorders.

Market Restraints

The global Calprotectin testing market faces some challenges that may hinder its growth. These include the following:

Calprotectin testing remains standardized.

One of the major constraints in the Calprotectin Testing Market is the lack of consistency in testing procedures and results interpretation. There is currently no standardized procedure for calprotectin testing, which can result in differences in results between laboratories and testing methods. This might make it challenging for healthcare providers to effectively diagnose and treat gastrointestinal illnesses like inflammatory bowel disease (IBD).

Furthermore, a lack of uniformity can cause misunderstanding among patients and healthcare providers, who may not completely comprehend the meaning of their test results. This can result in delays in diagnosis and treatment, which can have a detrimental influence on patient outcomes and raise healthcare expenses.

The lack of standardization also makes it challenging for businesses to produce and market calprotectin testing devices since they must navigate a complex regulatory landscape while simultaneously ensuring that their products fit the criteria of various markets and testing methodologies. This can be a considerable barrier to entry for new market participants, limiting competition and innovation.

Policies of Limited Reimbursement

The restrictive reimbursement policies for calprotectin testing are another major limitation of the Calprotectin Testing Market. Many healthcare systems and insurance companies do not pay the cost of calprotectin testing, making it difficult for individuals to obtain them and for healthcare providers to use them as a diagnostic tool. This can be a substantial impediment to market expansion since it limits the number of patients who can obtain calprotectin testing and so affects overall demand for these tests. It may also hinder manufacturers’ capacity to invest in research and development to enhance testing procedures and produce new goods.

In addition, a lack of reimbursement rules may result in discrepancies in access to care, since patients who cannot afford to pay for calprotectin testing out of pocket are less likely to receive an accurate diagnosis and appropriate treatment. This can have a detrimental impact on patient outcomes and raise long-term healthcare expenses.

Opportunities

The global Calprotectin testing market offers significant growth opportunities. These include the following:

Non-Invasive Diagnostic Tools are in high demand.

The increased need for non-invasive diagnostic technologies is one of the significant opportunities for the Calprotectin Testing Market. Calprotectin testing matches this trend because patients and healthcare providers are increasingly looking for diagnostic tests that are less invasive and more comfortable for patients. xCalprotectin testing is a non-invasive test that requires only a tiny stool Indication, making it a more pleasant and convenient choice for patients than endoscopy or colonoscopy. This can help to improve overall patient satisfaction by increasing patient compliance with testing.

Furthermore, calprotectin testing has been demonstrated to be a very accurate diagnostic tool for gastrointestinal illnesses such as inflammatory bowel disease (IBD), making it an important tool for healthcare practitioners. As more people become aware of the benefits of calprotectin testing, demand for these tests is anticipated to rise, opening up new opportunities for manufacturers and suppliers in the market.

Increased emphasis on non-invasive testing

Another significant opportunity for the Calprotectin Testing Market is the rising emphasis on non-invasive testing procedures. Non-invasive diagnostics are becoming increasingly popular since they are less uncomfortable, less expensive, and take less time than traditional intrusive examinations. Calprotectin testing is a non-invasive technique of identifying gastrointestinal illnesses such as inflammatory bowel disease (IBD), and as such, it is well-positioned to benefit from this trend. As patients and healthcare professionals seek less invasive diagnostic tools, demand for calprotectin testing is projected to rise.

Furthermore, new technology and testing methodologies are likely to improve the accuracy and reliability of calprotectin testing, making it an even more appealing alternative for patients and healthcare providers.

Competitive Landscape

Key Players

The global Calprotectin testing market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

Actim Oy
Calpro AS
BUHLMANN Laboratories AG
EagleBio
Cer Test Biotec S.L
EUROIMMUN Medizinische Labordiagnostika AG
Boditech Med Inc.
Biohit Oyj
American Laboratory Products Company, Ltd.
DIAsource ImmunoAssays S.A
R-Biopharm AG.
Abbexa
AccuBio Tech Co., Ltd.
Hangzhou Biotest Biotech Co., Ltd
Thermo Fisher Scientific
Epitope Diagnostics, Inc
Elabscience Biotechnology Inc
Vitassay Healthcare, S.L.U.
Beckman Coulter Inc.
Diasorin

These companies focus on product innovation, expanding their End-Users, and mergers and acquisitions to stay ahead in the market.

The major players in the global Calprotectin testing market are constantly striving to stay ahead by introducing new products and innovations.

Epitope Diagnostics created the Stool Indication Quantitative Collection and Extraction Device (sQED) in 2022 for the easy and accurate collection and extraction of stool specimens without the requirement for traditional weighing.

In 2022, Biohit Healthcare introduced the GastroPanel Quick Test, a non-invasive diagnostic test that combines Fecal Calprotectin with three additional biomarkers to determine gastrointestinal health.

Savyon Diagnostics introduced the Calprotectin FOB Combo in 2022, a dual marker test that combines Fecal Calprotectin and Fecal Occult Blood for the simultaneous diagnosis of inflammation and occult bleeding.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

Inflammatory Bowel Disease (IBD) is getting more common, and the necessity for early detection and treatment is becoming more generally acknowledged, which promotes market growth.
Market segmented by Test Kits, Sample, Indication, End-User, and region.
The Stool segment is the main segment due of its excellent accuracy and non-invasive character
In the Calprotectin testing market, the Ulcerative Colitis category is predicted to develop at the fastest CAGR.
North America is leading market growth; the market is highly competitive with key players including Actim Oy, Calpro AS, BUHLMANN Laboratories AG, EagleBio and Cer Test Biotec S.L.

Future Outlook

The Calprotectin Testing Market is predicted to expand steadily in the future years.
Increased demand for non-invasive diagnostic technologies is likely to boost market expansion.
New technology and testing methodologies are predicted to improve the accuracy and reliability of calprotectin testing.
In the coming years, rising knowledge of the benefits of calprotectin testing is projected to stimulate demand for these tests.

Segmentation

By Test Kits

- Calprotectin ELISA Test Kits
- Calprotectin Rapid Testing Kits

By Indication

- Stool
- Blood Serum/Plasma
- Other Biological Indications

By Indication

- Irritable Bowel Syndrome
- Ulcerative Colitis
- Crohn’s Disease
- Colorectal Cancer

By End User

- Hospitals
- Diagnostic Laboratories
- Specialty Clinics
By Region

North America
- Canada
- Mexico
Europe
- Germany
- France
- K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – DataModelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Calprotectin testing market
2.2. Global Calprotectin testing market, By Test Kits
2.3. Global Calprotectin testing market, By Sample
2.4. Global Calprotectin testing market, By Indication
2.5. Global Calprotectin testing market, By End-User
2.6. Global Calprotectin testing market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Calprotectin testing market Value, 2017-2030, (US$ Billions)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Test Kits
3.5.2. Sample
3.5.3. Indication
3.5.4. End-User
3.5.5. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Test Kits Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Test Kits Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Calprotectin testing market, By Test Kits
7.1. Global Calprotectin testing market Overview, By Test Kits
7.1.1. Global Calprotectin testing market Revenue Share, By Test Kits, 2022 Vs 2030 (in %)
7.2. Calprotectin ELISA Test Kits
7.2.1. Global Calprotectin testing market, By Region, 2017-2030 (US$ Billions)
7.3. Calprotectin Rapid Testing Kits
7.3.1. Global Calprotectin testing market, By Region, 2017-2030 (US$ Billions)

8. Global Calprotectin testing market, By Sample
8.1. Global Calprotectin testing market Overview, By Sample
8.1.1. Global Calprotectin testing market, By Sample, 2022 vs. 2030 (in%)
8.2. Stool
8.2.1. Global Calprotectin testing market, By Region, 2017-2030 (US$ Billions)
8.3. Blood Serum/Plasma
8.3.1. Global Calprotectin testing market, By Region, 2017-2030 (US$ Billions)
8.4. Others Blood Serum/Plasma
8.4.1. Global Calprotectin testing market, By Region, 2017-2030 (US$ Billions)

9. Global Calprotectin testing market, By Indication, 2017-2030(US$ Billions)
9.1. Global Calprotectin testing market Overview, By Indication
9.1.1. Global Calprotectin testing market, By Indication, 2022 vs 2030 (in%)
9.2. Irritable Bowel Syndrome
9.2.1. Global Calprotectin testing market, By Region, 2017-2030 (US$ Billions)
9.3. Ulcerative Colitis
9.3.1. Global Calprotectin testing market, By Region, 2017-2030 (US$ Billions)
9.4. Crohn’s Disease
9.4.1. Global Calprotectin testing market, By Region, 2017-2030 (US$ Billions)
9.5. Colorectal Cancer
9.5.1. Global Calprotectin testing market, By Region, 2017-2030 (US$ Billions)

10. Global Calprotectin testing market, By End-User, 2017-2030(US$ Billions)
10.1 Global Calprotectin testing market Overview, By End-User
10.1.1. Global Calprotectin testing market, By End-User, 2022 vs 2030 (in %)
10.2. Hospitals
10.2.1. Global Calprotectin testing market, By Region, 2017-2030 (US$ Billions)
10.3. Diagnostic Laboratories
10.3.1. Global Calprotectin testing market, By Region, 2017-2030 (US$ Billions)
10.4. Specialty Clinics
10.4.1. Global Calprotectin testing market, By Region, 2017-2030 (US$ Billions)

11. Global Calprotectin testing market, By Region
11.1. Global Calprotectin testing market Overview, by Region
11.1.1. Global Calprotectin testing market, By Region, 2022 vs 2030 (in%)
11.2. Test Kits
11.2.1. Global Calprotectin testing market, By Test Kits, 2017-2030 (US$ Billions)
11.3. Sample
11.3.1. Global Calprotectin testing market, By Sample, 2017-2030 (US$ Billions)
11.4. Indication
11.4.1. Global Calprotectin testing market, By Indication, 2017-2030 (US$ Billions)
11.5. End-User
11.5.1. Global Calprotectin testing market, By End-User, 2017-2030 (US$ Billions)

12. North America Calprotectin testing market Analysis
12.1. North America Calprotectin testing market, By Test Kits, 2017-2030(US$ Billions)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. North America Calprotectin testing market, By Sample, 2017-2030(US$ Billions)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. North America Calprotectin testing market, By Indication, 2017-2030(US$ Billions)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. North America Calprotectin testing market, By End-User, 2017-2030(US$ Billions)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. North America Calprotectin testing market, by Country, 2017-2030(US$ Billions)
12.5.1. North America Calprotectin testing market, by Country, 2022 Vs 2030 (in %)
12.5.2. U.S.
12.5.2.1. U.S. Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
12.5.2.2. U.S. Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
12.5.2.3. U.S. Calprotectin testing, By Sample, 2017-2030(US$ Billions)
12.5.2.4. U.S. Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
12.5.2.5. U.S. Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
12.5.3. Canada
12.5.3.1. Canada Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
12.5.3.2. Canada Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
12.5.3.3. Canada Calprotectin testing, By Sample, 2017-2030(US$ Billions)
12.5.3.4. Canada Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
12.5.3.5. Canada Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
12.5.4. Mexico
12.5.4.1. Mexico Calprotectin testing market Estimates and Forecast, 2017-2030 (US$ Billions)
12.5.4.2. Mexico Calprotectin testing, By Test Kits, 2017-2030 (US$ Billions)
12.5.4.3. Mexico Calprotectin testing, By Sample, 2017-2030 (US$ Billions)
12.5.4.4. Mexico Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
12.5.4.5. Mexico Calprotectin testing, By End-User, 2017-2030 (US$ Billions)

13. Europe Calprotectin testing market Analysis
13.1. Europe Calprotectin testing market, By Test Kits, 2017-2030(US$ Billions)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Europe Calprotectin testing market, By Sample, 2017-2030(US$ Billions)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Europe Calprotectin testing market, By Indication, 2017-2030(US$ Billions)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Europe Calprotectin testing market, By End-User, 2017-2030(US$ Billions)
13.4.1. Overview
13.4.2. SRC Analysis
13.5. Europe Calprotectin testing market, by Country, 2017-2030(US$ Billions)
13.5.1. EuropeCalprotectin testing market, by Country, 2022 Vs 2030 (in%)
13.5.2. Germany
13.5.2.1. Germany Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
13.5.2.2. Germany Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
13.5.2.3. Germany Calprotectin testing, By Sample, 2017-2030(US$ Billions)
13.5.3. Germany Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
13.5.4. Germany Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
13.5.5. France
13.5.5.1. France Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
13.5.5.2. France Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
13.5.5.3. France Calprotectin testing, By Sample, 2017-2030(US$ Billions)
13.5.5.4. France Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
13.5.5.5. France Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
13.5.6. UK
13.5.6.1. UK Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
13.5.6.2. UK Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
13.5.6.3. UK Calprotectin testing, By Sample, 2017-2030(US$ Billions)
13.5.6.4. UK Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
13.5.6.5. UK Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
13.5.7. Italy
13.5.7.1. Italy Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
13.5.7.2. Italy Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
13.5.7.3. Italy Calprotectin testing, By Sample, 2017-2030(US$ Billions)
13.5.7.4. Italy Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
13.5.7.5. Italy Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
13.5.8. Spain
13.5.8.1. Spain Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
13.5.8.2. Spain Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
13.5.8.3. Spain Calprotectin testing, By Sample, 2017-2030(US$ Billions)
13.5.8.4. Spain Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
13.5.8.5. Spain Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
13.5.9. Rest of Europe
13.5.9.1. Rest of Europe Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
13.5.9.2. Rest of Europe Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
13.5.9.3. Rest of Europe Calprotectin testing, By Sample, 2017-2030(US$ Billions)
13.5.9.4. Rest of Europe Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
13.5.9.5. Rest of Europe Calprotectin testing, By End-User, 2017-2030 (US$ Billions)

14. Asia Pacific Calprotectin testing market Analysis
14.1. Asia Pacific Calprotectin testing market, By Test Kits, 2017-2030(US$ Billions)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Asia Pacific Calprotectin testing market, By Sample, 2017-2030(US$ Billions)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Asia Pacific Calprotectin testing market, By Indication, 2017-2030(US$ Billions)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Asia Pacific Calprotectin testing market, By End-User, 2017-2030(US$ Billions)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. Asia Pacific Calprotectin testing market, by Country, 2017-2030(US$ Billions)
14.5.1. Asia PacificCalprotectin testing market, by Country, 2022 Vs 2030 (in%)
14.5.2. China
14.5.2.1. China Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
14.5.2.2. China Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
14.5.2.3. China Calprotectin testing, By Sample, 2017-2030(US$ Billions)
14.5.2.4. China Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
14.5.2.5. China Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
14.5.3. Japan
14.5.3.1. Japan Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
14.5.3.2. Japan Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
14.5.3.3. Japan Calprotectin testing, By Sample, 2017-2030(US$ Billions)
14.5.3.4. Japan Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
14.5.3.5. Japan Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
14.5.4. India
14.5.4.1. India Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
14.5.4.2. India Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
14.5.4.3. India Calprotectin testing, By Sample, 2017-2030(US$ Billions)
14.5.4.4. India Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
14.5.4.5. India Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
14.5.5. South Korea
14.5.5.1. South Korea Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
14.5.5.2. South Korea Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
14.5.5.3. South Korea Calprotectin testing, By Sample, 2017-2030(US$ Billions)
14.5.5.4. South Korea Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
14.5.5.5. South Korea Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
14.5.6. South-East Asia
14.5.6.1. South-East Asia Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
14.5.6.2. South-East Asia Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
14.5.6.3. South-East Asia Calprotectin testing, By Sample, 2017-2030(US$ Billions)
14.5.6.4. South-East Asia Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
14.5.6.5. South-East Asia Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
14.5.7. Rest of Asia Pacific
14.5.7.1. Rest of Asia Pacific Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
14.5.7.2. Rest of Asia Pacific Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
14.5.7.3. Rest of Asia Pacific Calprotectin testing, By Sample, 2017-2030(US$ Billions)
14.5.7.4. Rest of Asia Pacific Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
14.5.7.5. Rest of Asia Pacific Calprotectin testing, By End-User, 2017-2030 (US$ Billions)

15. Latin America Calprotectin testing market Analysis
15.1. Latin America Calprotectin testing market, By Test Kits, 2017-2030(US$ Billions)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Latin America Calprotectin testing market, By Sample, 2017-2030(US$ Billions)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Latin America Calprotectin testing market, By Indication, 2017-2030(US$ Billions)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Latin America Calprotectin testing market, By End-User, 2017-2030(US$ Billions)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Latin America Calprotectin testing market, by Country, 2017-2030(US$ Billions)
15.5.1. LatinAmerica Calprotectin testing market, by Country, 2022 Vs 2030 (in%)
15.5.2. Brazil
15.5.2.1. Brazil Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
15.5.2.2. Brazil Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
15.5.2.3. Brazil Calprotectin testing, By Sample, 2017-2030(US$ Billions)
15.5.2.4. Brazil Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
15.5.2.5. Brazil Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
15.5.3. Argentina
15.5.3.1. Argentina Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
15.5.3.2. Argentina Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
15.5.3.3. Argentina Calprotectin testing, By Sample, 2017-2030(US$ Billions)
15.5.3.4. Argentina Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
15.5.3.5. Argentina Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
15.5.4. Rest of Latin America
15.5.4.1. Rest of Latin America Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
15.5.4.2. Rest of Latin America Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
15.5.4.3. Rest of Latin America Calprotectin testing, By Sample, 2017-2030(US$ Billions)
15.5.4.4. Rest of Latin America Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
15.5.4.5. Rest of Latin America Calprotectin testing, By End-User, 2017-2030 (US$ Billions)

16. Middle East and Africa Calprotectin testing market Analysis
16.1. Middle East and Africa Calprotectin testing market, By Test Kits, 2017-2030(US$ Billions)
16.1.1. Overview
16.1.2. SRC Analysis
16.2. Middle East and Africa Calprotectin testing market, By Sample, 2017-2030(US$ Billions)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Middle East and Africa Calprotectin testing market, By Indication, 2017-2030(US$ Billions)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Middle East and Africa Calprotectin testing market, By End-User, 2017-2030(US$ Billions)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Middle East and Africa Calprotectin testing market, by Country, 2017-2030(US$ Billions)
16.5.1. Middle East and AfricaCalprotectin testing market, by Country, 2022 Vs 2030 (in%)
16.5.2. GCC Countries
16.5.2.1. GCC Countries Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
16.5.2.2. GCC Countries Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
16.5.2.3. GCC Countries Calprotectin testing, By Sample, 2017-2030(US$ Billions)
16.5.2.4. GCC Countries Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
16.5.2.5. GCC Countries Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
16.5.3. South Africa
16.5.3.1. South Africa Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
16.5.3.2. South Africa Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
16.5.3.3. South Africa Calprotectin testing, By Sample, 2017-2030(US$ Billions)
16.5.3.4. South Africa Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
16.5.3.5. South Africa Calprotectin testing, By End-User, 2017-2030 (US$ Billions)
16.5.4. Rest of Middle East and Africa
16.5.4.1. Rest of Middle East and Africa Calprotectin testing market Estimates and Forecast, 2017-2030(US$ Billions)
16.5.4.2. Rest of Middle East and Africa Calprotectin testing, By Test Kits, 2017-2030(US$ Billions)
16.5.4.3. Rest of Middle East and Africa Calprotectin testing, By Sample, 2017-2030(US$ Billions)
16.5.4.4. Rest of Middle East and Africa Calprotectin testing, By Indication, 2017-2030 (US$ Billions)
16.5.4.5. Rest of Middle East and Africa Calprotectin testing, By End-User, 2017-2030 (US$ Billions)

17. Company Profiles
17.1. Actim Oy
17.1.1. Company Overview
17.1.2. Test Kitss/Services Portfolio
17.1.3. Geographical Presence
17.1.4. Financial Summary
17.1.4.1. Market Revenue and Net Profit (2019-2022)
17.1.4.2. Business Segment Revenue Analysis
17.1.4.3. Geographical Revenue Analysis
17.2. Calpro AS
17.3. BUHLMANN Laboratories AG
17.4. EagleBio
17.5. Cer Test Biotec S.L
17.6. EUROIMMUN Medizinische Labordiagnostika AG
17.7. Boditech Med Inc.
17.8. Biohit Oyj
17.9. American Laboratory Products Company, Ltd.
17.10. DIAsource ImmunoAssays S.A
17.11. R-Biopharm AG.
17.12. Abbexa
17.13. AccuBio Tech Co., Ltd.
17.14. Hangzhou Biotest Biotech Co., Ltd
17.15. Thermo Fisher Scientific
17.16. Epitope Diagnostics, Inc
17.17. Elabscience Biotechnology Inc
17.18. Vitassay Healthcare, S.L.U.
17.19. Beckman Coulter Inc.
17.20. Diasorin

List of Figures
FIG. 1 Global Calprotectin testing market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Calprotectin testing market Segmentation
FIG. 4 Global Calprotectin testing market, By Test Kits, 2022(US$ Billions)
FIG. 5 Global Calprotectin testing market, By Sample, 2022(US$ Billions)
FIG. 6 Global Calprotectin testing market, By Indication, 2022 (US$ Billions)
FIG. 7 Global Calprotectin testing market, By End-User, 2022 (US$ Billions)
FIG. 8 Global Calprotectin testing market, by Geography, 2022(US$ Billions)
FIG. 9 Attractive Investment Proposition, By Test Kits, 2022
FIG. 10 Attractive Investment Proposition, By Sample, 2022
FIG. 11 Attractive Investment Proposition, By Indication, 2022
FIG. 12 Attractive Investment Proposition, By End-User, 2022
FIG. 13 Attractive Investment Proposition, by Geography, 2022
FIG. 14 Global Market Share Analysis of Key Calprotectin testing market Manufacturers, 2022
FIG. 15 Global Market Positioning of Key Calprotectin testing market Manufacturers, 2022
FIG. 16 Global Calprotectin testing market Value Contribution, By Test Kits, 2022&2030 (Value %)
FIG. 17 Global Calprotectin testingMarket, by Calprotectin ELISA Test Kits, Value, 2017-2030(US$ Billions)
FIG. 18 Global Calprotectin testingMarket, by Calprotectin Rapid Testing Kits, Value, 2017-2030(US$ Billions)
FIG. 19 Global Calprotectin testing market Value Contribution, By Sample, 2022&2030 (Value %)
FIG. 20 Global Calprotectin testingMarket, by Stool, Value, 2017-2030(US$ Billions)
FIG. 21 Global Calprotectin testingMarket, by Blood Serum/Plasma, 2017-2030(US$ Billions)
FIG. 22 Global Calprotectin testing market, by Others Biological Samples, 2017-2030(US$ Billions)
FIG. 23 Global Calprotectin testing market Value Contribution, By Indication, 2022 & 2030 (Value %)
FIG. 24 Global Calprotectin testing market, by Irritable Bowel Syndrome, Value, 2017-2030 (US$ Billions)
FIG. 25 Global Calprotectin testing market, by Ulcerative Colitis, 2017-2030 (US$ Billions)
FIG. 26 Global Calprotectin testing market, by Crohn’s Disease, 2017-2030 (US$ Billions)
FIG. 27 Global Calprotectin testing market, by Colorectal Cancer, 2017-2030 (US$ Billions)
FIG. 28 Global Calprotectin testing market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 29 Global Calprotectin testing market, by Hospitals, Value, 2017-2030 (US$ Billions)
FIG. 30 Global Calprotectin testing market, by Diagnostic Laboratories, Value, 2017-2030 (US$ Billions)
FIG. 31 Global Calprotectin testing market, by Specialty Clinics, Value, 2017-2030 (US$ Billions)
FIG. 32 North America Calprotectin testing market, 2017-2030 (US$ Billions)
FIG. 33 U.S. Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 34 Canada Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 35 Europe Calprotectin testing market, 2017-2030 (US$ Billions)
FIG. 36 Germany Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 37 France Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 38 U.K. Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 39 Italy Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 40 Spain Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 41 Rest of Europe Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 42 Asia Pacific Calprotectin testing market, 2017-2030 (US$ Billions)
FIG. 43 China Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 44 Japan Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 45 India Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 46 South Korea Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 47 South-East Asia Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 48 Rest of Asia Pacific Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 49 Latin America Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 50 Brazil Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 51 Mexico Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 52 Rest of Latin America Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 53 Middle East & Africa Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 54 GCC Countries Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 55 South Africa Calprotectin testing market, 2017-2030(US$ Billions)
FIG. 56 Rest of Middle East and Africa Calprotectin testing market, 2017-2030(US$ Billions)

List of Tables
TABLE 1 Market Snapshot: Global Calprotectin testingMarket
TABLE 2 Global Calprotectin testing market: Market Drivers Impact Analysis
TABLE 3 Global Calprotectin testing market: Market Restraints Impact Analysis
TABLE 4 Global Calprotectin testing market, by Competitive Benchmarking,2022
TABLE 5 Global Calprotectin testing market, by Geographical Presence Analysis, 2022
TABLE 6 Global Calprotectin testing market, by Key Strategies Analysis, 2022
TABLE 7 Global Calprotectin testing market, by Calprotectin ELISA Test Kits, By Region, 2017-2022(US$ Billions)
TABLE 8 Global Calprotectin testing market, by Calprotectin Rapid Testing Kits, By Region, 2023-2030(US$ Billions)
TABLE 9 Global Calprotectin testing market, by Stool, By Region, 2017-2022(US$ Billions)
TABLE 10 Global Calprotectin testing market, by Stool, By Region, 2023-2030(US$ Billions)
TABLE 11 Global Calprotectin testing market, by Blood Serum/Plasma, By Region, 2017-2022(US$ Billions)
TABLE 12 Global Calprotectin testing market, by Blood Serum/Plasma, By Region, 2023-2030(US$ Billions)
TABLE 13 Global Calprotectin testing market, by Irritable Bowel Syndrome, By Region, 2017-2022(US$ Billions)
TABLE 14 Global Calprotectin testing market, by Irritable Bowel Syndrome, By Region, 2023-2030(US$ Billions)
TABLE 15 Global Calprotectin testing market, by Ulcerative Colitis, By Region, 2017-2022(US$ Billions)
TABLE 16 Global Calprotectin testing market, by Ulcerative Colitis, By Region, 2023-2030(US$ Billions)
TABLE 17 Global Calprotectin testing market, by Crohn’s Disease, By Region, 2017-2022(US$ Billions)
TABLE 18 Global Calprotectin testing market, by Crohn’s Disease, By Region, 2023-2030(US$ Billions)
TABLE 19 Global Calprotectin testing market, by Colorectal Cancer, By Region, 2017-2022(US$ Billions)
TABLE 20 Global Calprotectin testing market, by Colorectal Cancer, By Region, 2023-2030(US$ Billions)
TABLE 21 Global Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 22 Global Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 23 Global Calprotectin testing market, By Sample, 2017-2022(US$ Billions)
TABLE 24 Global Calprotectin testing market, By Sample, 2023-2030(US$ Billions)
TABLE 25 Global Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 26 Global Calprotectin testing market, By Indication, 2023-2030 (US$ Billions)
TABLE 27 Global Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 28 Global Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 29 Global Calprotectin testing market, by Region, 2017-2022(US$ Billions)
TABLE 30 Global Calprotectin testing market, by Region, 2023-2030(US$ Billions)
TABLE 31 North America Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 32 North America Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 33 North America Calprotectin testing market, By Sample, 2017-2022(US$ Billions)
TABLE 34 North America Calprotectin testing market, By Sample, 2023-2030(US$ Billions)
TABLE 35 North America Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 36 North America Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 37 North America Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 38 North America Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 39 North America Calprotectin testing market, by Country, 2017-2022(US$ Billions)
TABLE 40 North America Calprotectin testing market, by Country, 2023-2030(US$ Billions)
TABLE 41 United States Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 42 United States Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 43 United States Calprotectin testing market, By Sample, 2017-2022(US$ Billions)
TABLE 44 United States Calprotectin testing market, By Sample, 2023-2030(US$ Billions)
TABLE 45 United States Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 46 United States Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 47 United States Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 48 United States Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 49 Canada Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 50 Canada Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 51 Canada Calprotectin testing market, by Samples, 2017-2022(US$ Billions)
TABLE 52 Canada Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 53 Canada Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 54 Canada Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 55 Canada Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 56 Canada Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 57 Mexico Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 58 Mexico Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 59 Mexico Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 60 Mexico Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 61 Mexico Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 62 Mexico Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 63 Mexico Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 64 Mexico Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 65 Europe Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 66 Europe Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 67 Europe Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 68 Europe Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 69 Europe Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 70 Europe Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 71 Europe Calprotectin testing market, by End-User, 2017-2022(US$ Billions)
TABLE 72 Europe Calprotectin testing market, by End-User, 2023-2030(US$ Billions)
TABLE 73 Germany Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 74 Germany Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 75 Germany Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 76 Germany Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 77 Germany Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 78 Germany Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 79 Germany Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 80 Germany Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 81 France Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 82 France Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 83 France Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 84 France Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 85 France Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 86 France Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 87 France Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 88 France Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 89 United Kingdom Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 90 United Kingdom Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 91 United Kingdom Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 92 United Kingdom Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 93 United Kingdom Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 94 United Kingdom Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 95 United Kingdom Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 96 United Kingdom Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 97 Italy Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 98 Italy Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 99 Italy Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 100 Italy Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 101 Italy Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 102 Italy Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 103 Italy Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 104 Italy Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 105 Spain Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 106 Spain Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 107 Spain Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 108 Spain Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 109 Spain Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 110 Spain Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 111 Spain Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 112 Spain Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 113 Rest of Europe Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 114 Rest of Europe Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 115 Rest of Europe Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 116 Rest of Europe Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 117 Rest of Europe Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 118 Rest of Europe Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 119 Rest of Europe Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 120 Rest of Europe Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 121
TABLE 122 Asia Pacific Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 123 Asia Pacific Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 124 Asia Pacific Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 125 Asia Pacific Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 126 Asia Pacific Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 127 Asia Pacific Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 128 Asia Pacific Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 129 Asia Pacific Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 130 China Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 131 China Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 132 China Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 133 China Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 134 China Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 135 China Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 136 China Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 137 China Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 138 Japan Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 139 Japan Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 140 Japan Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 141 Japan Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 142 Japan Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 143 Japan Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 144 Japan Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 145 Japan Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 146 India Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 147 India Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 148 India Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 149 India Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 150 India Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 151 India Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 152 India Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 153 India Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 154 South Korea Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 155 South Korea Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 156 South Korea Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 157 South Korea Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 158 South Korea Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 159 South Korea Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 160 South Korea Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 161 South Korea Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 162 South-East Asia Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 163 South-East Asia Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 164 South-East Asia Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 165 South-East Asia Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 166 South-East Asia Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 167 South-East Asia Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 168 South-East Asia Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 169 South-East Asia Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 170 Rest of Asia Pacific Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 171 Rest of Asia Pacific Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 172 Rest of Asia Pacific Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 173 Rest of Asia Pacific Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 174 Rest of Asia Pacific Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 175 Rest of Asia Pacific Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 176 Rest of Asia Pacific Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 177 Rest of Asia Pacific Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 178 Latin America Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 179 Latin America Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 180 Latin America Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 181 Latin America Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 182 Latin America Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 183 Latin America Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 184 Latin America Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 185 Latin America Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 186 Brazil Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 187 Brazil Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 188 Brazil Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 189 Brazil Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 190 Brazil Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 191 Brazil Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 192 Brazil Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 193 Brazil Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 194 Argentina Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 195 Argentina Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 196 Argentina Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 197 Argentina Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 198 Argentina Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 199 Argentina Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 200 Argentina Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 201 Argentina Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 202 Rest of Latin America Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 203 Rest of Latin America Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 204 Rest of Latin America Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 205 Rest of Latin America Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 206 Rest of Latin America Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 207 Rest of Latin America Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 208 Rest of Latin America Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 209 Rest of Latin America Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 210 Middle East and Africa Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 211 Middle East and Africa Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 212 Middle East and Africa Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 213 Middle East and Africa Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 214 Middle East and Africa Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 215 Middle East and Africa Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 216 Middle East and Africa Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 217 Middle East and Africa Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 218 GCC Countries Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 219 GCC Countries Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 220 GCC Countries Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 221 GCC Countries Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 222 GCC Countries Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 223 GCC Countries Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 224 GCC Countries Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 225 GCC Countries Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 226 South Africa Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 227 South Africa Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 228 South Africa Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 229 South Africa Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 230 South Africa Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 231 South Africa Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 232 South Africa Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 233 South Africa Calprotectin testing market, By End-User, 2023-2030(US$ Billions)
TABLE 234 Rest of Middle East and Africa Calprotectin testing market, By Test Kits, 2017-2022(US$ Billions)
TABLE 235 Rest of Middle East and Africa Calprotectin testing market, By Test Kits, 2023-2030(US$ Billions)
TABLE 236 Rest of Middle East and Africa Calprotectin testing market, by Sample, 2017-2022(US$ Billions)
TABLE 237 Rest of Middle East and Africa Calprotectin testing market, by Sample, 2023-2030(US$ Billions)
TABLE 238 Rest of Middle East and Africa Calprotectin testing market, By Indication, 2017-2022(US$ Billions)
TABLE 239 Rest of Middle East and Africa Calprotectin testing market, By Indication, 2023-2030(US$ Billions)
TABLE 240 Rest of Middle East and Africa Calprotectin testing market, By End-User, 2017-2022(US$ Billions)
TABLE 241 Rest of Middle East and Africa Calprotectin testing market, By End-User, 2023-2030(US$ Billions)

Frequently asked questions

What is the current size of the global Calprotectin testing market?

The global Calprotectin testing market was valued at USD 195.8 Billion in 2022.

What is the expected growth rate of the Calprotectin testing market between 2023 and 2030?

The Calprotectin testing market is expected to grow at a CAGR of 5.80% between 2023 and 2030, reaching USD 290.5 Billion in 2030.

Which segment is leading the market share in terms of Sample?

The Stool segment is the main segment due of its excellent accuracy and non-invasive character.

Which Indication segment governs the second largest market demand for Calprotectin testings in the world?

The Diagnostic Laboratories category is predicted to be the second-largest market for Calprotectin testing.

Which segment is expected to post the highest CAGR during the forecast period?

In the Calprotectin testing market, the Ulcerative Colitis category is predicted to develop at the fastest CAGR.

Which region is fueling the growth of the Calprotectin testing industry?

North America is projected to lead the Calprotectin testing market.

Who are the major players in the global Calprotectin testing market?

The top players include Actim Oy, Calpro AS, BUHLMANN Laboratories AG, EagleBio and Cer Test Biotec S.L. Other major players include Biohit Oyj, American Laboratory Products Company, Ltd, DIAsource ImmunoAssays S.A and R-Biopharm AG.

What are the major market drivers of the Calprotectin testing industry?

Inflammatory Bowel Disease (IBD) is growing increasingly widespread, and the need of early detection and treatment is becoming more widely recognized are the major market drivers.

What are the major market restraints of the Calprotectin testing industry?

Online Calprotectin testing is still standardized, and policies of limited reimbursement are in place are the major market restraints.

What are the major market opportunities of the Calprotectin testing industry?

Non-Invasive Diagnostic Tools are in great demand, and the emphasis on non-invasive testing is increasing are the major opportunities in the Calprotectin testing industry.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –